Shōjo Tsubaki

DSM acquires next-generation eubiotics platform start-up

Retrieved on: 
Tuesday, July 27, 2021

DSM already owns 38.5% of the shares of Midori and has today acquired the remaining 61.5% for a consideration of US$63m.

Key Points: 
  • DSM already owns 38.5% of the shares of Midori and has today acquired the remaining 61.5% for a consideration of US$63m.
  • Boston Massachusetts-based Midori has developed a technology platform that identifies glycans derived from natural food sugars that can precisely modulate how the gut microbiome functions in animals.
  • Such eubiotics can reduce the environmental footprint of animal farming and support the accelerated replacement of antibiotics in animal feed.
  • Midori's platform is highly synergetic with DSM's bioscience capability and current eubiotics portfolio, which was further strengthened through the acquisition of Biomin (as part of the Erber Group) .

Putting a Human Face on a Dark Part of History

Retrieved on: 
Wednesday, December 9, 2020

The personal nature of this book hooks the reader in a way that a traditional history book cannot.

Key Points: 
  • The personal nature of this book hooks the reader in a way that a traditional history book cannot.
  • We travel along the dark highways with Midori as he tries to get safely away from the West Coast.
  • Written in clear prose, with short chapters and amusing dialog, this book is an accessible approach to a difficult topic.
  • Paired with classroom discussion, Midori's story can literally put a human face on a dark part of history, and while dealing with an unjust and tragic time, also shows the power of the human spirit to follow one's dreams."